Revenue: The sum of all revenue fields included for a company's operating activities.
Revolution Medicines, Inc. (RVMD) Revenue data is not available for the most recently reported fiscal quarter, ending 2025-09-30.
| Income Statement Financials | |
|
Revenue |
-- |
$-305.21M |
|
-- |
|
-- |
|
$315.27M |
|
$-315.27M |
|
$10.06M |
|
$-305.21M |
|
$-305.21M |
|
$-305.21M |
|
$-305.21M |
|
$-305.21M |
|
$-305.21M |
|
$-315.27M |
|
$-316.65M |
|
189.23M |
|
189.23M |
|
$-1.61 |
|
$-1.61 |
|
| Balance Sheet Financials | |
$1.98B |
|
$32.93M |
|
$274.43M |
|
$2.25B |
|
$245.62M |
|
$256.51M |
|
$409.39M |
|
$655.02M |
|
$1.60B |
|
$1.53B |
|
$1.60B |
|
189.71M |
|
| Cash Flow Statement Financials | |
$-623.50M |
|
$43.18M |
|
$255.87M |
|
$546.76M |
|
$222.30M |
|
$-324.46M |
|
$84.69M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
8.05 |
|
-- |
|
-- |
|
0.14 |
|
0.16 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-637.57M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-19.11% |
|
-19.99% |
|
-13.55% |
|
-16.47% |
|
$8.42 |
|
$-3.37 |
|
$-3.29 |
|